Every innovation begins with an initial spark–an innovative idea that sets a ball in motion. But the road to bringing a new medical device to market is a long and arduous one, with challenges–everything from funding to FDA approvals.
A recent survey from IMS Health reveals that Vicodin is the most frequently prescribed painkiller in the US, with 131 million prescriptions written over the past year alone.
Internal development is key to Daiichi Sankyo Inc.’s new head, John Gargiulo, “because in order to be successful, we have to constantly be challenging ourselves to do things differently,” he says.
The move to e-promotion may be risky, but marketers can ill afford to wait. Omnicom’s Tom Harrison gives you permission to experiment with new types of messaging
Injectable arthritis drugs dominate in RA. They may lose some clout if cheaper, convenient orals get approved. Marc Iskowitz reports on pills in late testing and how much of an advantage they could have
Online resources (both branded and non-branded) for patients with rare diseases help replace feelings of isolation with a community that offers emotional and educational support, Marc Iskowitz finds
It’s often said that pharma is still playing catch-up with other industries in terms of engaging consumers via digital direct marketing. But among those savviest, which ones offer lessons for this industry?
The suddenly hot market for high-risk HPV tests, where Roche Diagnostics is launching against two entrenched brands, offers a window into a future of personalized medicine